NOREPINEPHRINE BITARTRATE

NOREPINEPHRINE BITARTRATE was reported 14748 times

NOREPINEPHRINE BITARTRATE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 APPENDICOLITH 295 0.7623
1 ANTACID THERAPY 94 0.7231
2 SLEEP DISORDER THERAPY 129 0.6515
3 ANALGESIC THERAPY 141 0.4393
4 DRUG THERAPY 136 0.4012
5 ANTICOAGULANT THERAPY 92 0.3239
6 VITAMIN B1 INCREASED 15 0.3191
7 SCHIZENCEPHALY 13 0.2889
8 CONGENITAL HIATUS HERNIA 64 0.2807
9 ELECTROCARDIOGRAM T WAVE ALTERNANS 12 0.2791
10 MALIGNANT MELANOMA STAGE 0 54 0.2584
11 MYOGLOBIN URINE PRESENT 60 0.2439
12 DIABETIC MACROANGIOPATHY 8 0.2424
13 CEREBRAL HAEMORRHAGE FOETAL 14 0.2295
14 SYSTOLIC ANTERIOR MOTION OF MITRAL VALVE 16 0.1905
15 BLOOD LACTIC ACID DECREASED 32 0.1860
16 MECHANICAL VENTILATION COMPLICATION 27 0.1812
17 CARDIAC OUTPUT INCREASED 30 0.1754
18 COVID-19 TREATMENT 11 0.1618
19 BURKHOLDERIA TEST POSITIVE 20 0.1613
20 BACTEROIDES INFECTION 40 0.1533
21 MYOCARDIAL CALCIFICATION 17 0.1453
22 PROPOFOL INFUSION SYNDROME 102 0.1447
23 VITAMIN B1 DECREASED 34 0.1355
24 ELECTROCARDIOGRAM U WAVE PRESENT 8 0.1290
25 LEFT VENTRICLE OUTFLOW TRACT OBSTRUCTION 38 0.1092
26 INSPIRATORY CAPACITY DECREASED 26 0.0939
27 HYPERDYNAMIC LEFT VENTRICLE 22 0.0894
28 DRY GANGRENE 54 0.0850
29 GENITAL EROSION 25 0.0842
30 HYPERPHOSPHATAEMIA 178 0.0827
31 CAFE AU LAIT SPOTS 8 0.0800
32 VASOPLEGIA SYNDROME 127 0.0774
33 BLOOD PHOSPHORUS INCREASED 211 0.0772
34 MEAN ARTERIAL PRESSURE DECREASED 18 0.0711
35 MYOCARDIAL STUNNING 9 0.0672
36 BRONCHOPULMONARY ASPERGILLOSIS ALLERGIC 59 0.0636
37 CRUSH SYNDROME 8 0.0567
38 SPLENIC ABSCESS 21 0.0516
39 CARDIOGENIC SHOCK 729 0.0508
40 ACID BASE BALANCE ABNORMAL 11 0.0491
41 ANION GAP 31 0.0489
42 CLOSTRIDIAL SEPSIS 11 0.0455
43 HYPERLACTACIDAEMIA 121 0.0451
44 PULMONARY HYPERTENSIVE CRISIS 12 0.0443
45 DISTRIBUTIVE SHOCK 100 0.0441
46 PHAEOCHROMOCYTOMA CRISIS 9 0.0425
47 NECROSIS ISCHAEMIC 19 0.0412
48 RENAL CORTICAL NECROSIS 9 0.0386
49 RESPIRATORY GAS EXCHANGE DISORDER 14 0.0377
50 GASTROINTESTINAL ISCHAEMIA 10 0.0361
51 EXTREMITY NECROSIS 61 0.0349
52 MYOCARDIAL DEPRESSION 9 0.0349
53 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 176 0.0347
54 PHARYNGEAL HAEMORRHAGE 42 0.0341
55 CYTOTOXIC OEDEMA 9 0.0340
56 FOETAL EXPOSURE DURING DELIVERY 23 0.0339
57 HAEMODYNAMIC INSTABILITY 258 0.0338
58 TOTAL LUNG CAPACITY DECREASED 54 0.0338
59 KIDNEY DUPLEX 8 0.0333
60 PERIPHERAL ISCHAEMIA 136 0.0333
61 ELECTROCARDIOGRAM P WAVE ABNORMAL 8 0.0327
62 MULTIPLE ORGAN DYSFUNCTION SYNDROME 919 0.0324
63 APPENDICITIS 302 0.0323
64 ANTIBIOTIC LEVEL ABOVE THERAPEUTIC 13 0.0320
65 ACETONAEMIA 8 0.0317
66 VENTRICULAR FIBRILLATION 352 0.0317
67 SYSTOLIC DYSFUNCTION 32 0.0304
68 CSF PRESSURE INCREASED 8 0.0301
69 LARYNGOMALACIA 10 0.0299
70 VASOCONSTRICTION 26 0.0297
71 ISCHAEMIC HEPATITIS 40 0.0292
72 HEPATIC ISCHAEMIA 9 0.0289
73 IRON DEFICIENCY 129 0.0287
74 HUMAN HERPESVIRUS 6 INFECTION REACTIVATION 10 0.0285
75 BLOOD URIC ACID INCREASED 163 0.0282
76 LOCKED-IN SYNDROME 13 0.0282
77 PULSELESS ELECTRICAL ACTIVITY 117 0.0280
78 STRESS CARDIOMYOPATHY 157 0.0270
79 DIABETES INSIPIDUS 65 0.0270
80 ELECTROCARDIOGRAM T WAVE AMPLITUDE DECREASED 9 0.0263
81 DISSEMINATED MUCORMYCOSIS 10 0.0254
82 HYPOPHOSPHATAEMIA 187 0.0253
83 MUCOSAL EROSION 23 0.0253
84 COMPARTMENT SYNDROME 65 0.0249
85 MATERNAL EXPOSURE DURING DELIVERY 24 0.0242
86 NECROTISING OESOPHAGITIS 12 0.0240
87 MYASTHENIA GRAVIS 193 0.0239
88 AORTIC STENOSIS 82 0.0235
89 TROPONIN INCREASED 178 0.0234
90 BLINDNESS CORTICAL 11 0.0224
91 LUNG OPACITY 58 0.0220
92 ACUTE LUNG INJURY 26 0.0219
93 HYPOPERFUSION 23 0.0219
94 ANION GAP INCREASED 29 0.0217
95 METHAEMOGLOBINAEMIA 50 0.0216
96 SHOCK 495 0.0215
97 REVERSIBLE CEREBRAL VASOCONSTRICTION SYNDROME 42 0.0213
98 PROCEDURAL HYPOTENSION 18 0.0212
99 BRONCHOPULMONARY DYSPLASIA 17 0.0211
100 PNEUMONIA NECROTISING 13 0.0201
101 ELECTROCARDIOGRAM QRS COMPLEX PROLONGED 103 0.0201
102 VENTRICULAR HYPOKINESIA 63 0.0196
103 MYOCARDIAL INJURY 22 0.0196
104 PLEURITIC PAIN 54 0.0195
105 INTESTINAL ISCHAEMIA 104 0.0189
106 SYSTEMIC CANDIDA 47 0.0187
107 BRASH SYNDROME 26 0.0185
108 MULTI-ORGAN FAILURE 320 0.0185
109 SYMMETRICAL DRUG-RELATED INTERTRIGINOUS AND FLEXURAL EXANTHEMA 15 0.0182
110 ABDOMINAL SEPSIS 16 0.0182
111 HAEMOTHORAX 52 0.0179
112 DEVICE INFUSION ISSUE 44 0.0177
113 ACIDOSIS 133 0.0174
114 EAR MALFORMATION 8 0.0173
115 ABDOMINAL COMPARTMENT SYNDROME 11 0.0173
116 ACUTE RESPIRATORY DISTRESS SYNDROME 305 0.0172
117 ELECTROCARDIOGRAM ST SEGMENT ELEVATION 57 0.0172
118 AMYLASE INCREASED 63 0.0171
119 RESPIRATORY ACIDOSIS 66 0.0168
120 TOXIC ENCEPHALOPATHY 84 0.0166
121 SYMPTOM MASKED 12 0.0165
122 ACINETOBACTER INFECTION 18 0.0164
123 HEPARIN-INDUCED THROMBOCYTOPENIA 80 0.0162
124 HYPERTHERMIA MALIGNANT 24 0.0161
125 ELECTROCARDIOGRAM ST SEGMENT DEPRESSION 35 0.0159
126 SEPTIC SHOCK 692 0.0159
127 NEONATAL ASPHYXIA 11 0.0155
128 RESPIRATORY SYMPTOM 44 0.0155
129 ELECTROCARDIOGRAM REPOLARISATION ABNORMALITY 12 0.0154
130 CARDIOVASCULAR INSUFFICIENCY 25 0.0153
131 CONTINUOUS HAEMODIAFILTRATION 15 0.0153
132 TOXIC EPIDERMAL NECROLYSIS 231 0.0152
133 NON-CARDIOGENIC PULMONARY OEDEMA 16 0.0151
134 ANAL STENOSIS 8 0.0150
135 OLIGURIA 93 0.0150
136 SEPSIS NEONATAL 12 0.0148
137 SERRATIA INFECTION 11 0.0148
138 RETINAL ISCHAEMIA 9 0.0147
139 INFANTILE APNOEA 12 0.0147
140 METABOLIC ACIDOSIS 468 0.0146
141 FUNGAEMIA 23 0.0146
142 UNMASKING OF PREVIOUSLY UNIDENTIFIED DISEASE 16 0.0145
143 DRUG EFFECT PROLONGED 8 0.0145
144 SUBCUTANEOUS EMPHYSEMA 14 0.0143
145 BRAIN DEATH 44 0.0142
146 DELAYED GRAFT FUNCTION 10 0.0141
147 JARISCH-HERXHEIMER REACTION 10 0.0140
148 LABORATORY TEST INTERFERENCE 11 0.0140
149 APALLIC SYNDROME 10 0.0138
150 HYPOXIC-ISCHAEMIC ENCEPHALOPATHY 36 0.0137
151 PHIMOSIS 10 0.0136
152 SPUTUM CULTURE POSITIVE 11 0.0135
153 ACUTE LEFT VENTRICULAR FAILURE 9 0.0134
154 NEURODEVELOPMENTAL DISORDER 9 0.0133
155 BLOOD MAGNESIUM INCREASED 12 0.0133
156 FUNGAL SEPSIS 11 0.0132
157 VENTRICULAR TACHYCARDIA 218 0.0132
158 APGAR SCORE LOW 17 0.0132
159 LOCAL ANAESTHETIC SYSTEMIC TOXICITY 14 0.0132
160 ANURIA 110 0.0128
161 ENTEROCOCCAL SEPSIS 10 0.0123
162 NODAL RHYTHM 18 0.0123
163 HYPERCAPNIA 37 0.0123
164 ARTERIOSPASM CORONARY 49 0.0122
165 DYSBIOSIS 10 0.0122
166 ASCITES 357 0.0121
167 VENTRICULAR ARRHYTHMIA 44 0.0120
168 PULSE ABSENT 57 0.0120
169 BREATH SOUNDS ABNORMAL 59 0.0120
170 CLOSTRIDIUM TEST POSITIVE 26 0.0118
171 ATRIOVENTRICULAR BLOCK FIRST DEGREE 51 0.0118
172 ISCHAEMIA 54 0.0117
173 CYTOKINE STORM 8 0.0117
174 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 31 0.0116
175 GANGRENE 70 0.0116
176 LACTIC ACIDOSIS 369 0.0114
177 COMA SCALE ABNORMAL 33 0.0114
178 FEAR 306 0.0114
179 CARDIAC OUTPUT DECREASED 10 0.0113
180 BACTERIAL INFECTION 211 0.0113
181 BLOOD CALCIUM INCREASED 98 0.0112
182 DISSEMINATED INTRAVASCULAR COAGULATION 157 0.0111
183 BENIGN PROSTATIC HYPERPLASIA 57 0.0110
184 EMBOLISM ARTERIAL 13 0.0108
185 TORSADE DE POINTES 84 0.0107
186 KLEBSIELLA SEPSIS 12 0.0106
187 GASTROINTESTINAL NECROSIS 31 0.0106
188 NODAL ARRHYTHMIA 9 0.0105
189 SHOCK HAEMORRHAGIC 85 0.0104
190 MUCORMYCOSIS 27 0.0104
191 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 178 0.0104
192 STENOTROPHOMONAS INFECTION 14 0.0103
193 CRITICAL ILLNESS 8 0.0103
194 BEZOAR 14 0.0101
195 LIVEDO RETICULARIS 21 0.0100
196 ESCHERICHIA TEST POSITIVE 12 0.0100
197 HYPERLIPIDAEMIA 119 0.0099
198 MUSCLE NECROSIS 9 0.0099
199 DILATED CARDIOMYOPATHY 10 0.0099
200 BLOOD LACTIC ACID INCREASED 52 0.0099
201 PUPIL FIXED 17 0.0098
202 COLOUR BLINDNESS 9 0.0098
203 PNEUMONIA KLEBSIELLA 18 0.0098
204 SEROTONIN SYNDROME 186 0.0097
205 BRADYCARDIA FOETAL 8 0.0096
206 DEVELOPMENTAL HIP DYSPLASIA 8 0.0096
207 PNEUMATOSIS INTESTINALIS 27 0.0095
208 CEREBELLAR INFARCTION 16 0.0095
209 PYELOCALIECTASIS 9 0.0094
210 RENAL INJURY 278 0.0093
211 CARDIAC ARREST 762 0.0092
212 CATHETER SITE HAEMORRHAGE 23 0.0092
213 RENAL TUBULAR NECROSIS 90 0.0092
214 CIRCULATORY COLLAPSE 156 0.0092
215 PERICARDIAL HAEMORRHAGE 20 0.0091
216 EXTRAVASATION 37 0.0090
217 MECHANICAL VENTILATION 17 0.0089
218 DEVICE RELATED SEPSIS 18 0.0089
219 FEAR OF DEATH 20 0.0089
220 PNEUMOMEDIASTINUM 16 0.0088
221 PATENT DUCTUS ARTERIOSUS 35 0.0088
222 TACHYARRHYTHMIA 22 0.0088
223 ANTICHOLINERGIC SYNDROME 14 0.0088
224 METABOLIC ALKALOSIS 14 0.0087
225 HYPOVOLAEMIA 51 0.0087
226 KLEBSIELLA INFECTION 44 0.0087
227 WRONG PRODUCT ADMINISTERED 58 0.0086
228 RESPIRATORY FAILURE 624 0.0085
229 PROCALCITONIN INCREASED 10 0.0085
230 HYPERVOLAEMIA 42 0.0085
231 FANCONI SYNDROME 12 0.0085
232 NECROSIS 47 0.0084
233 ANHEDONIA 221 0.0084
234 BRAIN HERNIATION 25 0.0084
235 RASH MORBILLIFORM 23 0.0083
236 DEVICE ALARM ISSUE 15 0.0083
237 END STAGE RENAL DISEASE 148 0.0081
238 PUPILLARY REFLEX IMPAIRED 15 0.0081
239 ANTIPHOSPHOLIPID SYNDROME 13 0.0081
240 RESPIRATORY DEPRESSION 99 0.0081
241 COAGULOPATHY 132 0.0079
242 TROPONIN T INCREASED 10 0.0079
243 MYOGLOBIN BLOOD INCREASED 12 0.0078
244 ACUTE RESPIRATORY FAILURE 150 0.0078
245 BRADYCARDIA 413 0.0078
246 BRADYPNOEA 21 0.0078
247 OPTIC NERVE INJURY 9 0.0078
248 BRUGADA SYNDROME 8 0.0077
249 SUPRAVENTRICULAR TACHYCARDIA 74 0.0077
250 CARDIOMYOPATHY 114 0.0077
251 RIGHT VENTRICULAR FAILURE 54 0.0077
252 RETROPERITONEAL HAEMORRHAGE 19 0.0077
253 METABOLIC ENCEPHALOPATHY 23 0.0077
254 SEPSIS 852 0.0076
255 HYPERNATRAEMIA 38 0.0076
256 BLOOD PH DECREASED 13 0.0076
257 ASPIRATION 83 0.0076
258 CARDIAC TAMPONADE 36 0.0076
259 ENTEROCOCCAL BACTERAEMIA 8 0.0075
260 HYPOXIA 266 0.0075
261 PRODUCT CONTAMINATION MICROBIAL 9 0.0075
262 HAEMATOMA MUSCLE 9 0.0075
263 KOUNIS SYNDROME 17 0.0075
264 IMMUNE EFFECTOR CELL-ASSOCIATED NEUROTOXICITY SYNDROME 44 0.0074
265 STRONGYLOIDIASIS 12 0.0074
266 HYPOTENSION 1483 0.0074
267 OPTIC ATROPHY 12 0.0074
268 HYPOTHERMIA 74 0.0073
269 HYPONATRAEMIA 411 0.0073
270 CAPILLARY LEAK SYNDROME 15 0.0072
271 RETROPERITONEAL HAEMATOMA 16 0.0072
272 ORTHOPNOEA 23 0.0072
273 TROPONIN I INCREASED 12 0.0072
274 LOW BIRTH WEIGHT BABY 57 0.0072
275 LEFT VENTRICULAR DYSFUNCTION 48 0.0072
276 VASODILATATION 18 0.0071
277 CEREBRAL HAEMATOMA 24 0.0071
278 CRYPTORCHISM 8 0.0071
279 MULTI-ORGAN DISORDER 14 0.0071
280 NEURALGIA 173 0.0071
281 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 183 0.0071
282 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 55 0.0071
283 FOETAL DISTRESS SYNDROME 15 0.0071
284 CEREBELLAR HAEMORRHAGE 10 0.0070
285 PSEUDOMONAS INFECTION 60 0.0070
286 ANGIOPATHY 39 0.0070
287 BLOOD CHLORIDE INCREASED 12 0.0069
288 ELECTROCARDIOGRAM ABNORMAL 54 0.0069
289 PSEUDOMONAL SEPSIS 12 0.0068
290 LEUKOCYTOSIS 124 0.0068
291 ENTEROCOCCAL INFECTION 33 0.0068
292 PULMONARY ARTERIAL PRESSURE INCREASED 11 0.0067
293 SKIN NECROSIS 35 0.0067
294 ELECTROCARDIOGRAM QT PROLONGED 242 0.0067
295 SINUS BRADYCARDIA 65 0.0067
296 BLOOD TEST ABNORMAL 94 0.0067
297 SINUS TACHYCARDIA 94 0.0066
298 ULCER 105 0.0066
299 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 25 0.0065
300 RHABDOMYOLYSIS 272 0.0065
301 BILIARY TRACT DISORDER 9 0.0065
302 CARDIOTOXICITY 58 0.0065
303 PNEUMOPERITONEUM 12 0.0065
304 ACUTE KIDNEY INJURY 991 0.0065
305 LIVER ABSCESS 21 0.0065
306 CARDIAC DYSFUNCTION 24 0.0064
307 BACTERIAL SEPSIS 21 0.0064
308 HYPOTONIA NEONATAL 10 0.0064
309 MEGACOLON 10 0.0064
310 BETA HAEMOLYTIC STREPTOCOCCAL INFECTION 8 0.0063
311 GOUT 114 0.0063
312 INCORRECT DRUG ADMINISTRATION RATE 27 0.0063
313 HYPERTRANSAMINASAEMIA 44 0.0063
314 SPLENIC INFARCTION 11 0.0063
315 LONG QT SYNDROME 15 0.0063
316 INTENTIONAL OVERDOSE 401 0.0062
317 RENAL INFARCT 9 0.0062
318 DACRYOSTENOSIS ACQUIRED 8 0.0062
319 PULMONARY SEPSIS 9 0.0062
320 BRONCHOPULMONARY ASPERGILLOSIS 48 0.0062
321 VENTRICULAR DYSFUNCTION 16 0.0062
322 ENDOTRACHEAL INTUBATION 17 0.0061
323 SYSTEMIC INFECTION 10 0.0060
324 RESUSCITATION 10 0.0060
325 PREMATURE DELIVERY 96 0.0060
326 HEPATORENAL SYNDROME 10 0.0059
327 BUNDLE BRANCH BLOCK LEFT 25 0.0059
328 INTRA-ABDOMINAL HAEMORRHAGE 14 0.0059
329 ATRIOVENTRICULAR BLOCK COMPLETE 39 0.0058
330 HYPOPROTEINAEMIA 11 0.0058
331 HYPERKALAEMIA 203 0.0058
332 COLITIS ISCHAEMIC 39 0.0058
333 CHOLESTASIS 111 0.0058
334 PRODUCT PACKAGING CONFUSION 14 0.0058
335 ATRIAL FLUTTER 46 0.0058
336 RENAL FAILURE 765 0.0058
337 ORGAN FAILURE 23 0.0057
338 ACUTE PULMONARY OEDEMA 32 0.0057
339 DEVICE CONNECTION ISSUE 12 0.0057
340 PROTHROMBIN TIME PROLONGED 34 0.0057
341 HYPERTHERMIA 43 0.0056
342 COMA 268 0.0056
343 TRANSAMINASES INCREASED 125 0.0056
344 PNEUMONIA STAPHYLOCOCCAL 11 0.0056
345 RESPIRATORY ALKALOSIS 9 0.0055
346 PULMONARY ALVEOLAR HAEMORRHAGE 31 0.0055
347 RALES 32 0.0055
348 ANGLE CLOSURE GLAUCOMA 14 0.0055
349 ATELECTASIS 53 0.0055
350 BUNDLE BRANCH BLOCK RIGHT 25 0.0054
351 CARDIAC FAILURE ACUTE 36 0.0054
352 CARDIAC FAILURE CHRONIC 23 0.0054
353 NECROTISING FASCIITIS 19 0.0054
354 MYOCARDIAL NECROSIS MARKER INCREASED 9 0.0054
355 FIBRIN D DIMER INCREASED 19 0.0053
356 ANAPHYLACTIC SHOCK 137 0.0053
357 TACHYPNOEA 72 0.0053
358 AREFLEXIA 14 0.0052
359 INJURY 368 0.0052
360 FIXED ERUPTION 9 0.0052
361 BACTERAEMIA 62 0.0052
362 HYPOVOLAEMIC SHOCK 25 0.0052
363 HYPERBILIRUBINAEMIA 54 0.0052
364 CYTOKINE RELEASE SYNDROME 104 0.0052
365 COAGULATION TIME PROLONGED 8 0.0052
366 AUTONOMIC NERVOUS SYSTEM IMBALANCE 15 0.0051
367 CARDIOPULMONARY FAILURE 20 0.0051
368 MITRAL VALVE INCOMPETENCE 58 0.0051
369 DRUG LEVEL BELOW THERAPEUTIC 28 0.0051
370 STAPHYLOCOCCAL SEPSIS 25 0.0051
371 BLOOD PRESSURE SYSTOLIC DECREASED 23 0.0051
372 INTERMITTENT CLAUDICATION 8 0.0050
373 BLOOD LACTATE DEHYDROGENASE INCREASED 80 0.0050
374 CLOSTRIDIAL INFECTION 17 0.0050
375 RENAL IMPAIRMENT 420 0.0050
376 BRAIN OEDEMA 63 0.0050
377 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 271 0.0049
378 TUMOUR LYSIS SYNDROME 43 0.0049
379 ENCEPHALOPATHY 120 0.0049
380 HAEMODIALYSIS 41 0.0049
381 BRAIN NATRIURETIC PEPTIDE INCREASED 15 0.0049
382 BLOOD POTASSIUM INCREASED 78 0.0048
383 HYPERCHOLESTEROLAEMIA 46 0.0048
384 ENTEROBACTER INFECTION 8 0.0048
385 HEPATIC CYTOLYSIS 60 0.0047
386 SEDATION COMPLICATION 12 0.0047
387 GRAFT VERSUS HOST DISEASE IN GASTROINTESTINAL TRACT 10 0.0047
388 HAEMOLYSIS 36 0.0047
389 PREMATURE BABY 140 0.0046
390 RENAL FAILURE ACUTE 197 0.0046
391 MICTURITION URGENCY 53 0.0046
392 PULMONARY OEDEMA 207 0.0046
393 PNEUMOTHORAX 73 0.0046
394 STAPHYLOCOCCAL BACTERAEMIA 20 0.0046
395 MYDRIASIS 59 0.0046
396 LIVER FUNCTION TEST INCREASED 98 0.0046
397 PNEUMONIA FUNGAL 18 0.0046
398 TACHYCARDIA 405 0.0046
399 CARDIO-RESPIRATORY ARREST 190 0.0045
400 JAUNDICE CHOLESTATIC 16 0.0045
401 ELECTROCARDIOGRAM T WAVE INVERSION 10 0.0045
402 NEONATAL RESPIRATORY DISTRESS SYNDROME 16 0.0045
403 TOXICITY TO VARIOUS AGENTS 756 0.0045
404 PULMONARY HAEMORRHAGE 35 0.0045
405 GENERALISED TONIC-CLONIC SEIZURE 74 0.0045
406 UNEVALUABLE EVENT 338 0.0045
407 VENOOCCLUSIVE LIVER DISEASE 22 0.0045
408 FULL BLOOD COUNT ABNORMAL 47 0.0044
409 FOETAL DEATH 23 0.0044
410 VASCULAR STENT THROMBOSIS 9 0.0044
411 HEPATITIS FULMINANT 13 0.0044
412 IMMUNE THROMBOCYTOPENIA 20 0.0044
413 PANCREATITIS NECROTISING 10 0.0043
414 HEPATIC FAILURE 131 0.0043
415 NEUROLOGICAL DECOMPENSATION 10 0.0043
416 DILATATION VENTRICULAR 9 0.0043
417 MYOCLONUS 51 0.0043
418 ATRIOVENTRICULAR BLOCK 33 0.0043
419 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 32 0.0043
420 HEPATIC NECROSIS 16 0.0042
421 OXYGEN SATURATION ABNORMAL 12 0.0042
422 POOR PERIPHERAL CIRCULATION 18 0.0042
423 PULMONARY HYPERTENSION 88 0.0042
424 CANDIDA INFECTION 71 0.0042
425 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 40 0.0042
426 BRAIN INJURY 42 0.0042
427 PNEUMONIA BACTERIAL 38 0.0041
428 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 216 0.0041
429 ESCHERICHIA INFECTION 34 0.0041
430 ILEUS 51 0.0041
431 NEPHROGENIC ANAEMIA 19 0.0041
432 LEFT VENTRICULAR FAILURE 14 0.0041
433 INFLAMMATORY MARKER INCREASED 20 0.0040
434 ACUTE HEPATIC FAILURE 55 0.0040
435 CLONUS 11 0.0040
436 BLOOD CREATININE INCREASED 262 0.0040
437 PATHOGEN RESISTANCE 36 0.0039
438 RENAL FAILURE CHRONIC 30 0.0039
439 HYPOALBUMINAEMIA 30 0.0039
440 VENTRICULAR EXTRASYSTOLES 40 0.0038
441 PLEURAL EFFUSION 234 0.0038
442 RESPIRATORY DISTRESS 106 0.0038
443 HEART VALVE INCOMPETENCE 11 0.0038
444 RESPIRATORY RATE DECREASED 12 0.0038
445 MENTAL STATUS CHANGES 106 0.0038
446 URINE OUTPUT DECREASED 33 0.0038
447 GENERAL PHYSICAL HEALTH DETERIORATION 436 0.0038
448 ESCHERICHIA URINARY TRACT INFECTION 16 0.0038
449 HYPERTRIGLYCERIDAEMIA 22 0.0038
450 BLOOD CHOLESTEROL INCREASED 175 0.0038
451 ACUTE CORONARY SYNDROME 31 0.0037
452 LEFT VENTRICULAR HYPERTROPHY 16 0.0037
453 STATUS EPILEPTICUS 42 0.0037
454 DEPRESSED LEVEL OF CONSCIOUSNESS 147 0.0037
455 MYOCARDIAL ISCHAEMIA 42 0.0037
456 NORMOCHROMIC NORMOCYTIC ANAEMIA 11 0.0037
457 ASPERGILLUS INFECTION 24 0.0037
458 TYPE IV HYPERSENSITIVITY REACTION 10 0.0036
459 THERAPY NON-RESPONDER 164 0.0036
460 COVID-19 PNEUMONIA 43 0.0036
461 RASH MACULO-PAPULAR 81 0.0036
462 PULMONARY CONGESTION 48 0.0036
463 IMMUNOSUPPRESSANT DRUG LEVEL INCREASED 12 0.0036
464 ASPARTATE AMINOTRANSFERASE INCREASED 192 0.0036
465 ISCHAEMIC CARDIOMYOPATHY 11 0.0036
466 ERYSIPELAS 18 0.0036
467 LUNG CONSOLIDATION 10 0.0036
468 BRONCHIECTASIS 24 0.0036
469 CLOSTRIDIUM DIFFICILE COLITIS 37 0.0035
470 CYTOMEGALOVIRUS COLITIS 8 0.0035
471 EJECTION FRACTION DECREASED 54 0.0035
472 HAEMANGIOMA 8 0.0035
473 ALANINE AMINOTRANSFERASE INCREASED 212 0.0034
474 DERMATITIS EXFOLIATIVE GENERALISED 12 0.0034
475 ESCHERICHIA SEPSIS 10 0.0034
476 UNRESPONSIVE TO STIMULI 89 0.0034
477 BLOOD PRESSURE DECREASED 229 0.0034
478 PNEUMONIA ASPIRATION 86 0.0034
479 TONGUE OEDEMA 13 0.0034
480 BLOOD CREATINE PHOSPHOKINASE INCREASED 98 0.0034
481 STRIDOR 10 0.0034
482 PRODUCT PACKAGING ISSUE 32 0.0034
483 ILEUS PARALYTIC 15 0.0034
484 PROCEDURAL HAEMORRHAGE 13 0.0033
485 MIXED LIVER INJURY 10 0.0033
486 SUSPECTED OFF LABEL USE 15 0.0033
487 THERAPEUTIC AGENT TOXICITY 11 0.0033
488 ATRIOVENTRICULAR BLOCK SECOND DEGREE 10 0.0033
489 ABDOMINAL DISTENSION 344 0.0033
490 DRUG LEVEL ABOVE THERAPEUTIC 15 0.0033
491 THROMBOCYTOPENIA 365 0.0033
492 UROSEPSIS 30 0.0032
493 INTRAVENTRICULAR HAEMORRHAGE 8 0.0032
494 DRUG LEVEL INCREASED 53 0.0032
495 HYPERAMMONAEMIA 16 0.0032
496 LUNG INFILTRATION 28 0.0032
497 BLOOD CREATINE INCREASED 14 0.0032
498 TRICUSPID VALVE INCOMPETENCE 25 0.0031
499 OBSTRUCTIVE AIRWAYS DISORDER 35 0.0031
500 ALTERED STATE OF CONSCIOUSNESS 68 0.0031
501 CONGESTIVE CARDIOMYOPATHY 13 0.0031
502 HEPATOTOXICITY 69 0.0031
503 NEUTROPENIC SEPSIS 22 0.0031
504 EMPHYSEMA 31 0.0031
505 PULMONARY EMBOLISM 292 0.0031
506 BLOOD BILIRUBIN INCREASED 83 0.0031
507 THROMBOSIS IN DEVICE 10 0.0030
508 NEPHROPATHY TOXIC 34 0.0030
509 AZOTAEMIA 12 0.0030
510 DELIRIUM 104 0.0030
511 CONDITION AGGRAVATED 908 0.0030
512 BLOOD UREA INCREASED 50 0.0030
513 DIALYSIS 42 0.0030
514 SPUTUM DISCOLOURED 28 0.0029
515 ENDOCARDITIS 15 0.0029
516 AUTOIMMUNE HAEMOLYTIC ANAEMIA 10 0.0029
517 PRODUCT LABEL CONFUSION 17 0.0029
518 CEREBRAL ISCHAEMIA 15 0.0029
519 CARDIOVASCULAR DISORDER 74 0.0029
520 HAEMOPTYSIS 81 0.0029
521 HYPOKALAEMIA 134 0.0029
522 INFUSION SITE EXTRAVASATION 18 0.0029
523 THROMBOSIS 231 0.0029
524 MULTIPLE INJURIES 18 0.0029
525 UPPER GASTROINTESTINAL HAEMORRHAGE 48 0.0029
526 DIABETES MELLITUS 217 0.0028
527 POST PROCEDURAL HAEMORRHAGE 33 0.0028
528 PNEUMONIA VIRAL 9 0.0028
529 SMALL FOR DATES BABY 14 0.0028
530 VENOUS THROMBOSIS 11 0.0028
531 HAEMOLYTIC ANAEMIA 25 0.0028
532 CORONARY ARTERY DISEASE 84 0.0028
533 BLOOD ALBUMIN DECREASED 22 0.0028
534 THROMBOCYTOSIS 10 0.0027
535 HYPOTONIA 27 0.0027
536 INTENTIONAL PRODUCT MISUSE 236 0.0027
537 CREPITATIONS 8 0.0027
538 BLOOD CULTURE POSITIVE 8 0.0027
539 GENERALISED OEDEMA 33 0.0027
540 EUGLYCAEMIC DIABETIC KETOACIDOSIS 11 0.0027
541 NERVOUS SYSTEM DISORDER 83 0.0027
542 CHOLECYSTITIS ACUTE 15 0.0026
543 INFARCTION 18 0.0026
544 EOSINOPHILIA 46 0.0026
545 DIASTOLIC DYSFUNCTION 8 0.0026
546 DRUG INTERACTION 411 0.0026
547 AORTIC VALVE INCOMPETENCE 11 0.0026
548 CORONARY ARTERY STENOSIS 13 0.0026
549 DECUBITUS ULCER 21 0.0026
550 JOINT INJURY 55 0.0026
551 STEVENS-JOHNSON SYNDROME 57 0.0026
552 HYPERGLYCAEMIA 93 0.0025
553 AMMONIA INCREASED 13 0.0025
554 FLUID OVERLOAD 37 0.0025
555 EOSINOPHILIC PNEUMONIA 8 0.0025
556 HYPERCALCAEMIA 31 0.0025
557 PERICARDIAL EFFUSION 58 0.0025
558 DRY MOUTH 203 0.0025
559 INTERNATIONAL NORMALISED RATIO INCREASED 71 0.0025
560 STAPHYLOCOCCAL INFECTION 82 0.0025
561 HYPOCALCAEMIA 47 0.0025
562 ATRIAL FIBRILLATION 241 0.0025
563 MOUTH HAEMORRHAGE 18 0.0025
564 POLYURIA 20 0.0024
565 LEG AMPUTATION 10 0.0024
566 MALNUTRITION 27 0.0024
567 ADVERSE REACTION 32 0.0024
568 SUBARACHNOID HAEMORRHAGE 24 0.0024
569 ANAPHYLACTIC REACTION 130 0.0024
570 CYANOSIS 37 0.0024
571 FOETAL EXPOSURE DURING PREGNANCY 190 0.0023
572 INTRACRANIAL PRESSURE INCREASED 13 0.0023
573 ELECTROLYTE IMBALANCE 27 0.0023
574 SUICIDE ATTEMPT 140 0.0023
575 ACUTE MYOCARDIAL INFARCTION 68 0.0023
576 LARGE INTESTINE PERFORATION 16 0.0023
577 APLASTIC ANAEMIA 12 0.0023
578 HYPERREFLEXIA 8 0.0023
579 EMOTIONAL DISTRESS 278 0.0023
580 DRUG INEFFECTIVE 3013 0.0023
581 CARDIOMEGALY 28 0.0023
582 NYSTAGMUS 12 0.0023
583 SLEEP DISORDER 159 0.0023
584 ADRENAL INSUFFICIENCY 27 0.0022
585 ANAEMIA 424 0.0022
586 MATERNAL EXPOSURE DURING BREAST FEEDING 9 0.0022
587 PULMONARY ARTERIAL HYPERTENSION 32 0.0022
588 HYPOGLYCAEMIA 107 0.0022
589 PNEUMOCYSTIS JIROVECII PNEUMONIA 22 0.0022
590 ANAPHYLACTOID REACTION 9 0.0022
591 EXTRASYSTOLES 15 0.0021
592 HEPATIC FUNCTION ABNORMAL 80 0.0021
593 HAEMORRHAGE INTRACRANIAL 32 0.0021
594 FOETAL GROWTH RESTRICTION 13 0.0021
595 PERIPHERAL VASCULAR DISORDER 11 0.0021
596 FACE OEDEMA 36 0.0021
597 LOWER RESPIRATORY TRACT INFECTION 97 0.0021
598 SWELLING 198 0.0021
599 MYOCARDITIS 24 0.0021
600 JAUNDICE 56 0.0021
601 FEBRILE NEUTROPENIA 138 0.0021
602 DERMATITIS BULLOUS 15 0.0021
603 HAEMATOCRIT DECREASED 41 0.0021
604 SKIN WARM 12 0.0021
605 EMBOLISM 17 0.0020
606 CEREBRAL INFARCTION 50 0.0020
607 CARDIAC FAILURE 164 0.0020
608 ECCHYMOSIS 14 0.0020
609 DRUG INTOLERANCE 197 0.0020
610 LOWER GASTROINTESTINAL HAEMORRHAGE 15 0.0020
611 ENCEPHALITIS 14 0.0020
612 CONJUNCTIVITIS 37 0.0020
613 HEPATITIS CHOLESTATIC 12 0.0020
614 UPPER RESPIRATORY TRACT INFECTION 92 0.0020
615 PRODUCT ADMINISTRATION ERROR 40 0.0020
616 EXPOSURE DURING PREGNANCY 122 0.0020
617 HYPOPHAGIA 50 0.0020
618 INJECTION SITE EXTRAVASATION 24 0.0019
619 AGRANULOCYTOSIS 36 0.0019
620 MATERNAL EXPOSURE DURING PREGNANCY 172 0.0019
621 POST PROCEDURAL COMPLICATION 37 0.0019
622 CARDIAC VALVE DISEASE 11 0.0019
623 VENTRICULAR SEPTAL DEFECT 11 0.0019
624 LIVER INJURY 47 0.0019
625 LIVE BIRTH 16 0.0019
626 PRODUCT ADMINISTRATION INTERRUPTED 15 0.0019
627 WRONG DRUG ADMINISTERED 17 0.0019
628 BLOOD ALKALINE PHOSPHATASE INCREASED 47 0.0019
629 PULMONARY MASS 28 0.0019
630 PULMONARY FIBROSIS 36 0.0019
631 INTESTINAL PERFORATION 21 0.0019
632 HYPOKINESIA 27 0.0019
633 ARRHYTHMIA 88 0.0019
634 LIVER DISORDER 82 0.0018
635 NORMAL NEWBORN 10 0.0018
636 LUNG DISORDER 90 0.0018
637 HYDROCEPHALUS 10 0.0018
638 DRUG RESISTANCE 47 0.0018
639 PROCEDURAL COMPLICATION 14 0.0018
640 OVERDOSE 393 0.0018
641 HAEMATOMA 47 0.0018
642 TRANSFUSION 19 0.0018
643 ABDOMINAL TENDERNESS 9 0.0018
644 PANCYTOPENIA 101 0.0018
645 ACCIDENTAL OVERDOSE 66 0.0018
646 TOXIC SKIN ERUPTION 18 0.0018
647 CLOSTRIDIUM DIFFICILE INFECTION 39 0.0018
648 ABDOMINAL PAIN 414 0.0018
649 CHOLANGITIS 11 0.0018
650 MOTOR DYSFUNCTION 18 0.0018
651 CHOLECYSTITIS 21 0.0018
652 PRODUCT USE IN UNAPPROVED INDICATION 434 0.0017
653 TRANSIENT ISCHAEMIC ATTACK 59 0.0017
654 HYPERTONIA 10 0.0017
655 CYTOMEGALOVIRUS INFECTION 29 0.0017
656 PERITONITIS 36 0.0017
657 ECONOMIC PROBLEM 26 0.0017
658 HEPATIC ENCEPHALOPATHY 16 0.0017
659 NEUROTOXICITY 30 0.0017
660 SERUM FERRITIN INCREASED 9 0.0017
661 ABORTION INDUCED 16 0.0017
662 RESPIRATORY RATE INCREASED 15 0.0017
663 GUILLAIN-BARRE SYNDROME 8 0.0017
664 HEPATOMEGALY 16 0.0016
665 OFF LABEL USE 1425 0.0016
666 PARALYSIS 23 0.0016
667 ARTERIOSCLEROSIS 15 0.0016
668 SOMNOLENCE 320 0.0016
669 DRUG LEVEL DECREASED 16 0.0016
670 PRODUCT PRESCRIBING ISSUE 34 0.0016
671 LEUKOPENIA 78 0.0016
672 ENTEROCOLITIS 9 0.0016
673 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 16 0.0016
674 LYMPHOPENIA 22 0.0016
675 CHROMATURIA 35 0.0015
676 METABOLIC DISORDER 9 0.0015
677 PNEUMONIA 500 0.0015
678 FAILURE TO THRIVE 8 0.0015
679 PLATELET COUNT DECREASED 163 0.0015
680 BODY TEMPERATURE INCREASED 31 0.0015
681 DEVICE FAILURE 23 0.0015
682 ARTERIOSCLEROSIS CORONARY ARTERY 10 0.0015
683 MUSCLE RIGIDITY 18 0.0015
684 MYOPATHY 13 0.0015
685 BLOOD DISORDER 12 0.0015
686 CONSTIPATION 326 0.0015
687 C-REACTIVE PROTEIN INCREASED 54 0.0015
688 HEPATOCELLULAR INJURY 21 0.0015
689 CEREBRAL HAEMORRHAGE 53 0.0015
690 BRONCHOSPASM 21 0.0015
691 MOUTH ULCERATION 31 0.0015
692 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 13 0.0015
693 PURPURA 13 0.0015
694 PANCREATITIS ACUTE 33 0.0015
695 SUBDURAL HAEMATOMA 21 0.0015
696 GLOMERULAR FILTRATION RATE DECREASED 18 0.0015
697 GINGIVAL BLEEDING 20 0.0015
698 GASTROINTESTINAL HAEMORRHAGE 122 0.0015
699 OXYGEN SATURATION DECREASED 82 0.0015
700 AGITATION 107 0.0015
701 HYPERTENSIVE CRISIS 16 0.0014
702 HYPOMAGNESAEMIA 20 0.0014
703 NEUROLEPTIC MALIGNANT SYNDROME 17 0.0014
704 DUODENAL ULCER 10 0.0014
705 HAEMORRHAGE 148 0.0014
706 HAEMORRHAGIC STROKE 11 0.0014
707 IRON DEFICIENCY ANAEMIA 13 0.0014
708 BLISTER 79 0.0014
709 ENTERITIS 9 0.0014
710 PNEUMONITIS 38 0.0014
711 SMALL INTESTINAL OBSTRUCTION 17 0.0014
712 TRANSPLANT REJECTION 11 0.0014
713 HYPERTENSION 289 0.0014
714 LYMPHOCYTE COUNT DECREASED 24 0.0014
715 LUNG INFECTION 21 0.0014
716 ISCHAEMIC STROKE 24 0.0013
717 LIVER FUNCTION TEST ABNORMAL 39 0.0013
718 SEIZURE 154 0.0013
719 OEDEMA 72 0.0013
720 INGUINAL HERNIA 8 0.0013
721 DERMATITIS ACNEIFORM 8 0.0013
722 CARDIAC FAILURE CONGESTIVE 105 0.0013
723 OEDEMA PERIPHERAL 159 0.0013
724 DIFFUSE LARGE B-CELL LYMPHOMA 10 0.0013
725 ANXIETY 369 0.0013
726 DRUG DIVERSION 8 0.0013
727 CONGENITAL ANOMALY 10 0.0013
728 MELAENA 28 0.0013
729 GAMMA-GLUTAMYLTRANSFERASE INCREASED 28 0.0013
730 DEEP VEIN THROMBOSIS 82 0.0013
731 RENAL CYST 10 0.0013
732 HAEMOGLOBIN DECREASED 128 0.0012
733 REBOUND EFFECT 14 0.0012
734 PERIPHERAL COLDNESS 17 0.0012
735 RESPIRATORY DISORDER 37 0.0012
736 PSYCHIATRIC SYMPTOM 9 0.0012
737 CORONAVIRUS INFECTION 8 0.0012
738 HYDRONEPHROSIS 9 0.0012
739 HEMIPLEGIA 10 0.0012
740 ABNORMAL LOSS OF WEIGHT 8 0.0012
741 LETHARGY 67 0.0012
742 DISABILITY 23 0.0012
743 RESPIRATORY ARREST 32 0.0012
744 CARDIAC MURMUR 10 0.0012
745 NEUTROPHIL COUNT DECREASED 47 0.0012
746 PALLOR 31 0.0011
747 HEPATITIS 29 0.0011
748 PYREXIA 390 0.0011
749 DIABETIC KETOACIDOSIS 27 0.0011
750 MEDICATION ERROR 62 0.0011
751 COLITIS 42 0.0011
752 BLOOD PRESSURE ABNORMAL 22 0.0011
753 DEVICE RELATED INFECTION 17 0.0011
754 HAEMATURIA 37 0.0011
755 ATRIAL SEPTAL DEFECT 9 0.0011
756 WHITE BLOOD CELL COUNT INCREASED 41 0.0011
757 BLOOD CALCIUM DECREASED 12 0.0011
758 TUBULOINTERSTITIAL NEPHRITIS 20 0.0011
759 NEUTROPENIA 144 0.0011
760 PSYCHOLOGICAL TRAUMA 9 0.0010
761 PYELONEPHRITIS 9 0.0010
762 APNOEA 8 0.0010
763 HAEMATEMESIS 26 0.0010
764 SPINAL PAIN 12 0.0010
765 VOMITING 481 0.0010
766 MUSCULOSKELETAL STIFFNESS 89 0.0010
767 DISEASE PROGRESSION 120 0.0010
768 MYOSITIS 9 0.0010
769 POLYNEUROPATHY 12 0.0010
770 CHRONIC KIDNEY DISEASE 76 0.0010
771 GASTRIC ULCER 19 0.0010
772 NO THERAPEUTIC RESPONSE 12 0.0010
773 CYTOPENIA 12 0.0010
774 NEUTROPHIL COUNT INCREASED 10 0.0010
775 ERYTHEMA MULTIFORME 9 0.0010
776 ACUTE MYELOID LEUKAEMIA 15 0.0010
777 DRUG ERUPTION 17 0.0010
778 DRUG-INDUCED LIVER INJURY 30 0.0010
779 TREATMENT FAILURE 79 0.0010
780 CORONARY ARTERY OCCLUSION 13 0.0009
781 HEMIPARESIS 16 0.0009
782 VASCULITIS 11 0.0009
783 OBESITY 15 0.0009
784 HEPATIC ENZYME INCREASED 62 0.0009
785 IMMUNOSUPPRESSION 8 0.0009
786 ANGIOEDEMA 40 0.0009
787 PANCREATITIS 46 0.0009
788 FUNGAL INFECTION 29 0.0009
789 HEART RATE DECREASED 30 0.0009
790 INCONTINENCE 9 0.0009
791 BONE MARROW FAILURE 17 0.0008
792 LOSS OF CONSCIOUSNESS 106 0.0008
793 GASTROENTERITIS 12 0.0008
794 PAIN 501 0.0008
795 HEPATIC STEATOSIS 15 0.0008
796 BLOOD TRIGLYCERIDES INCREASED 14 0.0008
797 EPISTAXIS 59 0.0008
798 GASTRIC HAEMORRHAGE 9 0.0008
799 DEVICE OCCLUSION 11 0.0008
800 SKIN DISORDER 26 0.0008
801 CELLULITIS 39 0.0008
802 THERAPY PARTIAL RESPONDER 12 0.0008
803 SPLENOMEGALY 9 0.0008
804 CONTRAINDICATED PRODUCT ADMINISTERED 23 0.0008
805 GASTROINTESTINAL DISORDER 68 0.0008
806 SARS-COV-2 TEST POSITIVE 10 0.0008
807 HEART RATE INCREASED 75 0.0008
808 DYSPNOEA 423 0.0007
809 SKIN DISCOLOURATION 34 0.0007
810 IMMUNODEFICIENCY 11 0.0007
811 DEATH 633 0.0007
812 DRUG TOXICITY 10 0.0007
813 BLOOD POTASSIUM DECREASED 22 0.0007
814 DERMATITIS ALLERGIC 9 0.0007
815 WHEEZING 42 0.0007
816 CEREBROVASCULAR ACCIDENT 119 0.0007
817 MYELOSUPPRESSION 25 0.0007
818 MYELODYSPLASTIC SYNDROME 10 0.0007
819 PLATELET COUNT INCREASED 9 0.0007
820 ABSCESS 11 0.0007
821 ORAL CANDIDIASIS 9 0.0007
822 ASTHMA 77 0.0007
823 DRUG WITHDRAWAL SYNDROME NEONATAL 10 0.0007
824 ORAL HERPES 13 0.0007
825 EPILEPSY 20 0.0007
826 DISEASE RECURRENCE 31 0.0007
827 EMOTIONAL DISORDER 20 0.0006
828 RASH ERYTHEMATOUS 31 0.0006
829 COORDINATION ABNORMAL 9 0.0006
830 COGNITIVE DISORDER 30 0.0006
831 CONFUSIONAL STATE 103 0.0006
832 CONVULSION 36 0.0006
833 TREMOR 103 0.0006
834 INTERSTITIAL LUNG DISEASE 30 0.0006
835 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 18 0.0006
836 DEHYDRATION 80 0.0006
837 DEPRESSION 135 0.0006
838 MYOCARDIAL INFARCTION 103 0.0006
839 DRUG DISPENSING ERROR 9 0.0006
840 COVID-19 103 0.0006
841 FLATULENCE 33 0.0006
842 INFLAMMATION 30 0.0006
843 MENTAL DISORDER 25 0.0006
844 APHASIA 17 0.0006
845 NAUSEA 444 0.0006
846 DYSARTHRIA 21 0.0006
847 HYPERTHYROIDISM 8 0.0006
848 COMPLICATION ASSOCIATED WITH DEVICE 8 0.0006
849 CHOLELITHIASIS 18 0.0005
850 NO ADVERSE EVENT 99 0.0005
851 RASH MACULAR 19 0.0005
852 URINARY RETENTION 18 0.0005
853 NERVOUSNESS 28 0.0005
854 PRODUCT PREPARATION ERROR 11 0.0005
855 MUCOSAL INFLAMMATION 14 0.0005
856 INTESTINAL OBSTRUCTION 20 0.0005
857 BLOOD SODIUM DECREASED 10 0.0005
858 RED BLOOD CELL COUNT DECREASED 15 0.0005
859 GASTROOESOPHAGEAL REFLUX DISEASE 42 0.0005
860 RESTLESSNESS 19 0.0005
861 ASTHENIA 195 0.0005
862 INTENTIONAL PRODUCT USE ISSUE 44 0.0005
863 BLOOD PRESSURE FLUCTUATION 12 0.0005
864 PAIN IN JAW 14 0.0005
865 FEEDING DISORDER 10 0.0005
866 HYPERHIDROSIS 62 0.0005
867 SYNCOPE 48 0.0005
868 URINARY TRACT INFECTION 81 0.0005
869 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 16 0.0005
870 PRODUCTIVE COUGH 22 0.0005
871 PRODUCT DISPENSING ERROR 10 0.0005
872 TREATMENT NONCOMPLIANCE 25 0.0005
873 DRUG ADMINISTRATION ERROR 14 0.0005
874 COMPLETED SUICIDE 38 0.0005
875 DYSPHAGIA 43 0.0005
876 CHILLS 53 0.0005
877 DIABETES MELLITUS INADEQUATE CONTROL 8 0.0005
878 WHITE BLOOD CELL COUNT DECREASED 48 0.0004
879 HYPOTHYROIDISM 14 0.0004
880 WITHDRAWAL SYNDROME 18 0.0004
881 SKIN ULCER 11 0.0004
882 DYSPNOEA EXERTIONAL 16 0.0004
883 FAECES DISCOLOURED 9 0.0004
884 PRODUCT USE ISSUE 78 0.0004
885 SKIN EXFOLIATION 35 0.0004
886 BLOOD PRESSURE SYSTOLIC INCREASED 8 0.0004
887 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 29 0.0004
888 SYSTEMIC LUPUS ERYTHEMATOSUS 14 0.0004
889 BLINDNESS 16 0.0004
890 BLOOD PRESSURE INCREASED 60 0.0004
891 MUSCLE TWITCHING 9 0.0004
892 INFECTION 56 0.0004
893 DRUG ABUSE 32 0.0004
894 SEDATION 10 0.0004
895 DERMATITIS 8 0.0004
896 HAEMATOCHEZIA 21 0.0004
897 GASTRITIS 10 0.0004
898 INFUSION RELATED REACTION 25 0.0004
899 RECTAL HAEMORRHAGE 16 0.0004
900 HYPERSENSITIVITY 69 0.0004
901 MENTAL IMPAIRMENT 9 0.0004
902 PRESYNCOPE 9 0.0004
903 DEVICE MALFUNCTION 26 0.0004
904 RENAL DISORDER 17 0.0004
905 CHEST PAIN 67 0.0004
906 URTICARIA 60 0.0004
907 ERYTHEMA 73 0.0004
908 HEART RATE IRREGULAR 8 0.0004
909 DISORIENTATION 14 0.0004
910 MUSCULAR WEAKNESS 40 0.0004
911 THERAPEUTIC RESPONSE DECREASED 21 0.0003
912 CARDIAC DISORDER 32 0.0003
913 DEVICE DELIVERY SYSTEM ISSUE 9 0.0003
914 SKIN LESION 9 0.0003
915 WOUND 9 0.0003
916 THERAPEUTIC PRODUCT EFFECT DECREASED 14 0.0003
917 THERAPY CESSATION 16 0.0003
918 COUGH 87 0.0003
919 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 55 0.0003
920 LABORATORY TEST ABNORMAL 9 0.0003
921 IMPAIRED HEALING 10 0.0003
922 RASH 131 0.0003
923 INCORRECT DOSE ADMINISTERED 68 0.0003
924 HALLUCINATION 22 0.0003
925 DIARRHOEA 188 0.0003
926 NIGHTMARE 10 0.0003
927 SWOLLEN TONGUE 9 0.0003
928 LYMPHADENOPATHY 10 0.0003
929 AGGRESSION 14 0.0003
930 EXTRA DOSE ADMINISTERED 11 0.0003
931 MALIGNANT NEOPLASM PROGRESSION 27 0.0003
932 FLUID RETENTION 13 0.0003
933 UNDERDOSE 18 0.0002
934 ACCIDENTAL EXPOSURE TO PRODUCT 25 0.0002
935 BACK PAIN 56 0.0002
936 DISTURBANCE IN ATTENTION 13 0.0002
937 ABDOMINAL PAIN UPPER 48 0.0002
938 BRONCHITIS 17 0.0002
939 DECREASED APPETITE 53 0.0002
940 CHEST DISCOMFORT 23 0.0002
941 MYALGIA 38 0.0002
942 MOBILITY DECREASED 16 0.0002
943 DYSURIA 8 0.0002
944 STOMATITIS 13 0.0002
945 PRODUCT DOSE OMISSION ISSUE 62 0.0002
946 SPEECH DISORDER 11 0.0002
947 DRUG WITHDRAWAL SYNDROME 18 0.0002
948 NEUROPATHY PERIPHERAL 19 0.0002
949 ADVERSE EVENT 18 0.0002
950 HEADACHE 122 0.0002
951 ECZEMA 10 0.0002
952 DYSPHONIA 11 0.0002
953 SUICIDAL IDEATION 17 0.0002
954 IRRITABILITY 11 0.0002
955 ILL-DEFINED DISORDER 11 0.0002
956 FATIGUE 140 0.0002
957 PALPITATIONS 21 0.0002
958 DEVICE ISSUE 16 0.0002
959 HERPES ZOSTER 10 0.0002
960 MALAISE 76 0.0002
961 DIZZINESS 86 0.0002
962 DEPRESSED MOOD 9 0.0002
963 AMNESIA 11 0.0002
964 DISCOMFORT 10 0.0002
965 BLOOD GLUCOSE INCREASED 30 0.0002
966 FLUSHING 16 0.0002
967 FALL 52 0.0002
968 CONTUSION 15 0.0002
969 FEELING HOT 9 0.0001
970 DYSPEPSIA 14 0.0001
971 DRUG DOSE OMISSION BY DEVICE 11 0.0001
972 BONE PAIN 8 0.0001
973 PERIPHERAL SWELLING 21 0.0001
974 MUSCLE SPASMS 25 0.0001
975 PARAESTHESIA 21 0.0001
976 SINUSITIS 13 0.0001
977 THERAPY INTERRUPTED 9 0.0001
978 VISUAL IMPAIRMENT 15 0.0001
979 ABDOMINAL DISCOMFORT 20 0.0001
980 PRODUCT QUALITY ISSUE 16 0.0001
981 WEIGHT DECREASED 32 0.0001
982 INSOMNIA 30 0.0001
983 PRURITUS 43 0.0001
984 PAIN IN EXTREMITY 32 0.0001
985 GAIT DISTURBANCE 20 0.0001
986 MEMORY IMPAIRMENT 14 0.0001
987 INFLUENZA 11 0.0001
988 ARTHRALGIA 39 0.0001
989 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 17 0.0001
990 HYPOAESTHESIA 12 0.0001
991 HOSPITALISATION 12 0.0001
992 NASOPHARYNGITIS 14 0.0001
993 ALOPECIA 13 0.0001
994 VISION BLURRED 9 0.0001
995 WEIGHT INCREASED 13 0.0001
996 DRUG DEPENDENCE 8 0.0000